China FDA to Require Registration, Training of Medical Reps

International Pharmaceutical Regulatory Monitor
A A
China FDA released draft regulations that would require medical representatives in China to register, and mandate that medical product marketing authorization holders provide adequate training.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor